Inside the Issue: Current and Future Management of ER-Positive Metastatic Breast Cancer After Disease Progression on a CDK4/6 Inhibitor

episode

Breast Cancer Update not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

2026-09-24- KSR - Hour 1 1h 4m · 24 Sep 2026 · KSR

Is This The October Surprise? (Ep. 2602) 1h 30m · 24 Sep 2026 · The Dan Bongino Show

Sage Advice From Granny Bingo 19 min · 24 Sep 2026 · It's A Lot with Abbie Chatfield

Trump, Xi Begin State Visit, Oil Soars on Iran Threat, More 7 min · 24 Sep 2026 · Bloomberg News Now

The Single Dumbest Thing Ever Said About the Miami Heat | Hour 2 37 min · 24 Sep 2026 · The Dan Le Batard Show

The Podcast is Pregnant: Thursday, September 24th, 2026 1h 12m · 24 Sep 2026 · The Toast

Report any issue

Source

Recorded24 Aug 2023

Publisherfeeds.captivate.fm ↗

Handlerec:5010190

Show notes

Dr Aditya Bardia from Massachusetts General Hospital in Boston, Massachusetts, and Dr Erika Hamilton from Sarah Cannon Research Institute in Nashville, Tennessee, discuss approved and novel treatment approaches for ER-positive metastatic breast cancer that has progressed on prior CDK4/6 inhibitor therapy.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in